18 results
Topical drug formulations, comparison and considerations

#pharmacology #table #medications #comparison #drugs #treatment #pharmacotherapy #dermatology
Topical drug formulations ... , comparison and ... pharmacology #table #medications ... #comparison #drugs ... #treatment #pharmacotherapy
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
RIPE Therapy - Drug ... Microbiologically Confirmed Pulmonary ... Tuberculosis - ... Therapy #regimens #medications ... #Guidelines #Treatment
Doses of Antituberculosis Drugs for Adults and Children - IDSA
First-line drugs:
 • Isoniazid
 • Rifampin
 •
Antituberculosis Drugs ... and Children - IDSA ... First-line drugs ... Moxifloxacin #Tuberculosis ... #Drugs #Medications
IDSA - Doses of Drugs for Treatment of Adults and Children with Multidrug-Resistant Tuberculosis
Step 1 Levofloxacin,
IDSA - Doses of ... Drugs for Treatment ... Multidrug-Resistant Tuberculosis ... pharmacology #dosing #idsa ... #drugs
Asthma Medications and Mechanism of Action

#Asthma #Medications #Drugs #Pulmonary #Pharmacology #Management #Treatment
Asthma Medications ... Action #Asthma #Medications ... #Drugs #Pulmonary ... Pharmacology #Management #Treatment
PDE5 inhibitors are usually the drugs of first choice for erectile dysfunction.

PDE5 inhibitors enhance an erection that is
are usually the drugs ... Drug interactions ... #pharmacology #comparison ... #treatment #medications ... #dosing #drugs
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Individualized Treatment ... Resistant Tuberculosis ... MDRTB #management #Treatment ... pharmacology #dosing #idsa
Summary table of the mechanism of action, side effect and contraindications of commonly used non-steroidal anti-inflammatory
anti-inflammatory drugs ... pharmacology #table #comparison ... #medications #treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
inhibitors • Injection drug ... • HIV: 2/3 pulmonary ... Treatment: Active ... Initiating Treatment ... Diagnosis #Management #Treatment
IDSA Summary of recommendations on drugs for use in a treatment regimen for patients with
multidrug-resistant tuberculosis,
IDSA Summary of ... recommendations on drugs ... multidrug-resistant tuberculosis ... MultiDrugResistant #Tuberculosis ... pharmacology #ebm #idsa